A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered
Topical serums: who they fit Topical GHK-Cu is often used for fine lines, texture, and post-procedure recovery, because it is easy to add and easy to stop if irritation shows up
They also slow gastric emptying, prolonging the feeling of fullness after meals and reducing overall caloric consumption
Confirm first Current Medication Availability Call before booking to confirm whether the clinic currently works with branded, compounded, injectable, or oral options and how prescriptions are filled
Women with diabetes have a higher risk of recurrent vaginal yeast infections
68 (Supplement 1)